News

Investigating multi-dimensional problems in drug substance

"Finding solutions to the biggest challenges faced during drug substance development relies on properly integrating analytical and production expertise."

Quotient's Sr. Director of Sciences & Technology, Gareth Jenkins, and Head of Drug Substance, Paul Quigley, have shared their insights into the importance of investigations during drug substance development. This article in the Chemistry Detectives issue of Chemistry World explores how solutions are found to enhance scalability, efficiency and economy. It provides details on how metabolic and pharmacokinetic studies are used to determine drug compound fate and how our solid-state team investigates physical forms. You can also learn about our use of synthetic biology to accelerate process development.

You can read the full article here on the Chemistry World website

We use cookies to help us to improve our site and enables us to the best possible service and customer experience. By clicking accept you are agreeing to let us share your data with select third parties for analytics and marketing purposes.